anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Sequoia Pitch

Arc collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 43,093
Current window 16,351-16,380
Pages 1,437
Rows per page 30
Arc: Sequoia Pitchclear collectionreset all
18 30 60

Arc

16,351-16,380 of 43,093

filter-aware
10
Uses a central diagram to bridge two lists of arguments.ads-tec Energy | SPAC Presentation Deck | 43 slides · ads-tec Energy
Pitch deck Investment bank Beat · ProblemLoop · Why Now1 hit
11
Uses a water tank analogy to explain the difference between power (flow rate) and energy (total volume).ads-tec Energy | SPAC Presentation Deck | 43 slides · ads-tec Energy
Pitch deck Investment bank Beat · ProblemLoop · Why Now1 hit
13
The slide uses a comparative framework to justify the need for the company's battery-buffered technology.ads-tec Energy | SPAC Presentation Deck | 43 slides · ads-tec Energy
Pitch deck Investment bank Beat · Solution1 hit
14
The slide uses a comparative layout to showcase product portfolio capabilities.ads-tec Energy | SPAC Presentation Deck | 43 slides · ads-tec Energy
Pitch deck Investment bank Beat · Solution1 hit
16
The slide uses a mix of bulleted market facts and quantitative charts to justify the market opportunity for ultra-fast charging infrastructure.ads-tec Energy | SPAC Presentation Deck | 43 slides · ads-tec Energy
Pitch deck Investment bank Beat · Market Size1 hit
17
Uses a timeline-style arrow to represent a spectrum of locations/segments.ads-tec Energy | SPAC Presentation Deck | 43 slides · ads-tec Energy
Pitch deck Investment bank Beat · Market Size1 hit
18
Uses a maturity-model style progression (First movers -> Fast followers -> Ultimate opportunity).ads-tec Energy | SPAC Presentation Deck | 43 slides · ads-tec Energy
Pitch deck Investment bank Beat · Market Size1 hit
21
The chart shows a clear upward trend in HCT procedures from 2000 to 2018, segmented by indication (AML, MDS, ALL).TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
22
Uses a process flow diagram to show the patient journey and the specific point of failure (relapse).TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
24
The slide shows three distinct charts: a time-course line graph, a bar chart for survival at 90 hours, and a bar chart comparing cell viability across different HA-1 genotypes in AML and ALL cell lines.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · Traction1 hit
25
The slide uses microscopy imagery to demonstrate therapeutic efficacy.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · Traction1 hit
26
The chart shows a scatter plot where the vast majority of data points are at zero, indicating no off-target binding.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · Traction1 hit
27
The slide uses a process flow to explain patient stratification for a clinical trial.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · Traction1 hit
28
TScan Therapeutics | IPO Presentation Deck | 43 slidesTScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · Traction1 hit
29
Uses a Venn diagram to show overlap in Head & Neck cancers, and a central 'ImmunoBank' repository feeding into multiplexed TCR-T arms.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · Traction1 hit
30
The slide highlights target expression overlap to justify multiplexed therapy.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · Traction1 hit
31
The chart shows fold-enrichment of protein fragments, highlighting a 'Novel Head & Neck Target' alongside positive controls.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · Traction1 hit
32
The chart shows fold-enrichment of protein fragments, highlighting three specific targets identified from patient data.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · Traction1 hit
33
The chart uses a log scale on the y-axis to compare expression levels across multiple tissue types.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · Traction1 hit
34
Slide 34 from TScan Therapeutics deck.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · Traction1 hit
35
The slide uses a process flow to demonstrate the company's R&D pipeline progress.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · Traction1 hit
07
Uses visual metaphors (spoons, icons) to communicate health risks.Zevia | IPO Presentation Deck | 46 slides · Zevia
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
09
Uses a pie chart to illustrate market penetration gap.Zevia | IPO Presentation Deck | 46 slides · Zevia
Pitch deck Investment bank Beat · Market SizeLoop · Cost Of Inaction1 hit
10
The slide uses a 5-column layout to highlight key product attributes.Zevia | IPO Presentation Deck | 46 slides · Zevia
Pitch deck Investment bank Beat · SolutionLoop · Cost Of Inaction1 hit
29
The slide uses a map to visualize the geographic distribution of co-manufacturers, warehouses, and consolidators.Zevia | IPO Presentation Deck | 46 slides · Zevia
Pitch deck Investment bank Beat · Business ModelLoop · Cost Of Inaction1 hit
37
Zevia | IPO Presentation Deck | 46 slidesZevia | IPO Presentation Deck | 46 slides · Zevia
Pitch deck Investment bank Beat · FinancialsLoop · Cost Of Inaction1 hit
38
LTM is as of 3/31/2021. Adjusted EBITDA is a non-GAAP financial measure.Zevia | IPO Presentation Deck | 46 slides · Zevia
Pitch deck Investment bank Beat · FinancialsLoop · Cost Of Inaction1 hit
39
Includes a footnote regarding non-GAAP financial measures.Zevia | IPO Presentation Deck | 46 slides · Zevia
Pitch deck Investment bank Beat · FinancialsLoop · Cost Of Inaction1 hit
40
The chart displays quarterly data points across multiple years, grouped by quarter, with specific YoY growth percentages provided below.Zevia | IPO Presentation Deck | 46 slides · Zevia
Pitch deck Investment bank Beat · FinancialsLoop · Cost Of Inaction1 hit
41
Zevia | IPO Presentation Deck | 46 slidesZevia | IPO Presentation Deck | 46 slides · Zevia
Pitch deck Investment bank Beat · FinancialsLoop · Cost Of Inaction1 hit